CCNE1 amplification indicates highly-aggressive component and suppressed immune status among different carcinomas
CCNE1 amplification (CCA) is a critical molecular alteration in tumors and a potential targetable for emerging therapies, however, its pan-cancer clinicopathological features and tumor immune microenvironment (TIME) characteristics remain poorly defined. This study compared CCA and non-amplified tumors across lung (LUAD), gastric (GA), ovarian (OV), and uterine (UC) carcinomas using our institutional cohort (n = 433) and public datasets (TCGA/cBioPortal), integrating histopathology, multi-omics, and detection validation (NGS/FISH/IHC). CCA exhibited aggressive histologic differentiation across tumor types, including the primitive enterocyte phenotype in GA, high-grade serous carcinoma/carcinosarcoma in UC/OV, and frequent neuroendocrine transformation in recurrent LUAD. All CCA groups had worse prognoses than their non-amplified counterparts. Cellular experiments validated the phenotypic transformation and unregulated proliferation following CCNE1 overexpression. Single-cell spatial transcriptomics and IHC revealed an immunosuppressive TIME across tumor types. Moreover, dual-color FISH demonstrated optimal detection consistency. This multi-cancer, multi-omics analysis establishes CCNE1 amplification as a hallmark of aggressive, immunoevasive carcinomas. This study integrated CCNE1-amplified carcinoma (CCA) pathological differentiation features across multiple cancer types from a histopathological perspective, breaking through single-organ limitations. In multiple cancer types, CCNE1 amplification indicates enhanced aggressiveness. Single-cell spatial transcriptomics was employed to analyze the tumor immune microenvironment characteristics of CCA.
Authors
- Jianming Ying (ORCID: https://orcid.org/0000-0003-2692-4052)
- Jiali Mu
- Zuxuan Zhao
- Liyan Xue (ORCID: https://orcid.org/0000-0001-5185-0126)
- Fanshuang Zhang (ORCID: https://orcid.org/0000-0002-9870-9303)
- Ziyang Zhou (ORCID: https://orcid.org/0000-0003-0382-1229)
- Zihan Sun (ORCID: https://orcid.org/0000-0002-9676-3074)
- Lina Gao
- Weihua Li
- Bingzhi Wang
- Shun Wang
- Hong Zhao
- Lei Guo
- Shuhang Wang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- China-Japan Friendship Hospital (CN)
- Cancer Hospital of Chinese Academy of Medical Sciences (CN)
- State Key Laboratory of Molecular Oncology (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1186/s12967-026-09156-0
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00